Rong W. Zablocki

Rong W. Zablocki

Auto-generated profile, based on publicly available information

Rong W. Zablocki

Hebert Wertheim School of Public Health, University of California, San Diego, La Jolla, CA, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2025 in Circulation
Verified
Journal Article
Closed access
SHSheri J. Hartman
Sheri J. Hartman
ALAndrea Z. LaCroix
Andrea Z. LaCroix
Dorothy D SearsDorothy D Sears
Dorothy D Sears
LNLoki Natarajan
Loki Natarajan
RZRong W. Zablocki
Rong W. Zablocki
DRDori Rosenberg
Dori Rosenberg
BACKGROUND: Public health and clinical guidelines identify the importance of sedentary behaviors for cardiovascular diseases, particularly among postmenopausal women. The goal of this trial was to compare the behavioral and physiological impacts of 2 distinct approaches to changing sedentary behaviors. METHODS: Overweight or obese sedentary postmenopausal women (N=407) were randomly assigned to 1 of 3 study conditions for 3 months: (1) healthy living (control), (2) reduce sitting time (sit less), and (3) increase sit-to-stand transitions (STSTs; sit-to-stand). Each study arm received 7 individual health coach sessions across 12 weeks. At baseline and 3 months, participants had fasting blood drawn, had blood pressure measured, and wore thigh (activPAL) and hip (ActiGraph) accelerometers for 7 days. Linear mixed models evaluated each intervention arm compared with the control (healthy living) arm. RESULTS: A total of 388 women (95%) completed the 3-month trial. The sit less arm reduced total sitting time by 58 minutes per day more than the healthy living arm (95% CI, –82.9 to –33.6; P <0.001) but did not change STSTs (–1 STST/day [95% CI, –9.4 to 6.5]; P =0.72). Conversely, the sit-to-stand arm significantly increased STST by 26 STST per day more than the healthy living arm (95% CI, 17.71 to 33.64; P <0.001) but did not differ in change to sitting time (–10 min/day [95% CI, –34.6 to 14.9]; P =0.44). The sit-to-stand arm had significant decreases in diastolic blood pressure compared with the healthy living arm (–2.24 mm Hg [95% CI, –4.08 to –0.40]; P =0.02) and similar decreases in systolic blood pressure compared with the healthy living arm (–3.33 mm Hg [95% CI, –6.32 to –0.33]; P =0.03), although it did not reach the a priori significance threshold of P <0.025. There were no significant intervention effects on blood pressure for the sit less arm and no intervention effects for the glucoregulatory outcomes for either arm. CONCLUSIONS: This trial demonstrated the feasibility of changing sedentary behaviors as well as the distinct nature of sitting time and STST. Increasing STST improved blood pressure in overweight and obese postmenopausal women within 3 months. Focusing on increasing STST may be an achievable behavioral target to reduce cardiovascular disease risk in postmenopausal women. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03473145.

19 December 2023 in JMIR Cancer
Verified
Journal Article
Open access
RTRowena M Tam
Rowena M Tam
RZRong W Zablocki
Rong W Zablocki
CLChenyu Liu
Chenyu Liu
HNHari K Narayan
Hari K Narayan
LNLoki Natarajan
Loki Natarajan
SHSheri J Hartman
Sheri J Hartman
Background: Sedentary behavior among breast cancer survivors is associated with increased risk of poor physical function and worse quality of life. While moderate to vigorous physical activity can improve outcomes for cancer survivors, many are unable to engage in that intensity of physical activity. Decreasing sitting time may be a more feasible behavioral target to potentially mitigate the impact of cancer and its treatments. Objective: The purpose of this study was to investigate the feasibility and preliminary impact of an intervention to reduce sitting time on changes to physical function and quality of life in breast cancer survivors, from baseline to a 3-month follow-up. Methods: Female breast cancer survivors with self-reported difficulties with physical function received one-on-one, in-person personalized health coaching sessions aimed at reducing sitting time. At baseline and follow-up, participants wore the activPAL (thigh-worn accelerometer; PAL Technologies) for 3 months and completed physical function tests (4-Meter Walk Test, Timed Up and Go, and 30-Second Chair Stand) and Patient-Reported Outcomes Measurement Information System (PROMIS) self-reported outcomes. Changes in physical function and sedentary behavior outcomes were assessed by linear mixed models. Results: On average, participants (n=20) were aged 64.5 (SD 9.4) years; had a BMI of 30.4 (SD 4.5) kg/m2; and identified as Black or African American (n=3, 15%), Hispanic or Latina (n=4, 20%), and non-Hispanic White (n=14, 55%). Average time since diagnosis was 5.8 (SD 2.2) years with participants receiving chemotherapy (n=8, 40%), radiotherapy (n=18, 90%), or endocrine therapy (n=17, 85%). The intervention led to significant reductions in sitting time: activPAL average daily sitting time decreased from 645.7 (SD 72.4) to 532.7 (SD 142.1; β=–112.9; P=.001) minutes and average daily long sitting bouts (bout length ≥20 min) decreased from 468.3 (SD 94.9) to 366.9 (SD 150.4; β=–101.4; P=.002) minutes. All physical function tests had significant improvements: on average, 4-Meter Walk Test performance decreased from 4.23 (SD 0.95) to 3.61 (SD 2.53; β=–.63; P=.002) seconds, Timed Up and Go performance decreased from 10.30 (SD 3.32) to 8.84 (SD 1.58; β=–1.46; P=.003) seconds, and 30-Second Chair Stand performance increased from 9.75 (SD 2.81) to 13.20 completions (SD 2.53; β=3.45; P<.001). PROMIS self-reported physical function score improved from 44.59 (SD 4.40) to 47.12 (SD 5.68; β=2.53; P=.05) and average fatigue decreased from 52.51 (SD 10.38) to 47.73 (SD 8.43; β=–4.78; P=.02). Conclusions: This 3-month pilot study suggests that decreasing time spent sitting may be helpful for breast cancer survivors experiencing difficulties with physical function and fatigue. Reducing sitting time is a novel and potentially more feasible approach to improving health and quality of life in cancer survivors.

30 September 2026 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
SHSheri J Hartman
Sheri J Hartman
LSLucy Y Shao
Lucy Y Shao
RZRong W Zablocki
Rong W Zablocki
LNLoki Natarajan
Loki Natarajan
TATim A Ahles
Tim A Ahles
BPBarbara A Parker
Barbara A Parker
Background: Cognitive problems are common after breast cancer, yet few randomized controlled trials have evaluated interventions to address them. This study tested whether a 12-month exercise intervention improved cognition in breast cancer survivors. Methods: Breast cancer survivors (n = 253) were randomized to an exercise arm with a remotely delivered intervention or a Health & Wellness arm receiving calls on healthy aging topics at the same frequency. The 6-month intervention (primary end-point) was followed by a 6-month maintenance phase (secondary end-point). At baseline, 3, 6, and 12 months, participants wore an accelerometer and completed the PROMIS Cognitive Abilities Questionnaire, the NIH Toolbox Digit symbol test (Processing Speed), and a neurocognitive battery assessing memory, executive function, and attention. Linear mixed models compared outcomes between arms. Results: The Exercise arm had greater increases in moderate to vigorous physical activity (18 minutes/day baseline, 23.5 minutes/day 12 months) than the Health & Wellness arm (15 minutes/day baseline, 15.5 minutes/day 12 months) at all follow-ups (P-values < .01). No significant between-group effects were observed for primary outcomes of self-reported cognition or processing speed at 6 or 12 months (P-values > .05). However, for secondary outcomes, the Exercise arm had greater improvements than the Health & Wellness arm in attention (6 months: b = 0.14, P = 0.03; 12 months: b = 0.21, P=.002), and memory (6 months: b = 0.18, P < .01). Conclusion: A remotely delivered Exercise intervention was not superior to a Health & Wellness intervention for self-reported cognition or processing speed. However, secondary outcomes suggest sustained improvements in attention and short-term benefits in memory. Exercise warrants further investigation as a strategy to support cognitive health in breast cancer survivors. Trial registration: ClinicalTrials.gov Identifier: NCT04049695

5 July 2022 in arXiv
Verified
Preprint
Open access
PDF file
YWYiren Wang
Yiren Wang
FTFatima Tuz-Zahra
Fatima Tuz-Zahra
RZRong Zablocki
Rong Zablocki
CDChongzhi Di
Chongzhi Di
Marta Maja JankowskaMarta Maja Jankowska
Marta Maja Jankowska
LNLoki Natarajan
Loki Natarajan
Cohort studies are increasingly using accelerometers for physical activity and sedentary behavior estimation. These devices tend to be less error-prone than self-report, can capture activity throughout the day, and are economical. However, previous methods for estimating sedentary behavior based on hip-worn data are often invalid or suboptimal under free-living situations and subject-to-subject variation. In this paper, we propose a local Markov switching model that takes this situation into account, and introduce a general procedure for posture classification and sedentary behavior analysis that fits the model naturally. Our method features changepoint detection methods in time series and also a two stage classification step that labels data into 3 classes(sitting, standing, stepping). Through a rigorous training-testing paradigm, we showed that our approach achieves > 80% accuracy. In addition, our method is robust and easy to interpret.

30 June 2023 in JMIR Preprints
Verified
Preprint
Open access
RTRowena M Tam
Rowena M Tam
RZRong W Zablocki
Rong W Zablocki
CLChenyu Liu
Chenyu Liu
HNHari K Narayan
Hari K Narayan
LNLoki Natarajan
Loki Natarajan
SHSheri J Hartman
Sheri J Hartman
BACKGROUND Sedentary behavior among breast cancer survivors is associated with increased risk of poor physical function and worse quality of life. While moderate to vigorous physical activity can improve outcomes for cancer survivors, many are unable to engage in that intensity of physical activity. Decreasing sitting time may be a more feasible behavioral target to potentially mitigate the impact of cancer and its treatments. OBJECTIVE The purpose of this study was to investigate the feasibility and preliminary impact of an intervention to reduce sitting time on changes to physical function and quality of life in breast cancer survivors, from baseline to a 3-month follow-up. METHODS Female breast cancer survivors with self-reported difficulties with physical function received one-on-one, in-person personalized health coaching sessions aimed at reducing sitting time. At baseline and follow-up, participants wore the activPAL (thigh-worn accelerometer; PAL Technologies) for 3 months and completed physical function tests (4-Meter Walk Test, Timed Up and Go, and 30-Second Chair Stand) and Patient-Reported Outcomes Measurement Information System (PROMIS) self-reported outcomes. Changes in physical function and sedentary behavior outcomes were assessed by linear mixed models. RESULTS On average, participants (n=20) were aged 64.5 (SD 9.4) years; had a BMI of 30.4 (SD 4.5) kg/m2; and identified as Black or African American (n=3, 15%), Hispanic or Latina (n=4, 20%), and non-Hispanic White (n=14, 55%). Average time since diagnosis was 5.8 (SD 2.2) years with participants receiving chemotherapy (n=8, 40%), radiotherapy (n=18, 90%), or endocrine therapy (n=17, 85%). The intervention led to significant reductions in sitting time: activPAL average daily sitting time decreased from 645.7 (SD 72.4) to 532.7 (SD 142.1; β=–112.9; P=.001) minutes and average daily long sitting bouts (bout length ≥20 min) decreased from 468.3 (SD 94.9) to 366.9 (SD 150.4; β=–101.4; P=.002) minutes. All physical function tests had significant improvements: on average, 4-Meter Walk Test performance decreased from 4.23 (SD 0.95) to 3.61 (SD 2.53; β=–.63; P=.002) seconds, Timed Up and Go performance decreased from 10.30 (SD 3.32) to 8.84 (SD 1.58; β=–1.46; P=.003) seconds, and 30-Second Chair Stand performance increased from 9.75 (SD 2.81) to 13.20 completions (SD 2.53; β=3.45; P<.001). PROMIS self-reported physical function score improved from 44.59 (SD 4.40) to 47.12 (SD 5.68; β=2.53; P=.05) and average fatigue decreased from 52.51 (SD 10.38) to 47.73 (SD 8.43; β=–4.78; P=.02). CONCLUSIONS This 3-month pilot study suggests that decreasing time spent sitting may be helpful for breast cancer survivors experiencing difficulties with physical function and fatigue. Reducing sitting time is a novel and potentially more feasible approach to improving health and quality of life in cancer survivors.

1 January 2026 in Journal for the Measurement of Physical Behaviour
Verified
Journal Article
Closed access
PDF file
JMJasmine Morales
Jasmine Morales
RZRong W. Zablocki
Rong W. Zablocki
SHSheri J. Hartman
Sheri J. Hartman
AKArun Kumar
Arun Kumar
AKAnimesh Kumar
Animesh Kumar
LNLoki Natarajan
Loki Natarajan
Background : Sedentary behavior (SB) is a risk factor for cardiometabolic disease. Existing cut points of hip-worn accelerometers to quantify SB underestimate sedentary bout durations by ignoring posture. To address this, we previously developed Convolutional Neural Network Hip Accelerometer Posture (CHAP), a deep-learning algorithm that predicts sitting and breaks from sitting. In this study, we applied CHAP to a randomized controlled trial to externally validate its accuracy for classifying sitting versus nonsitting and estimating intervention-related changes in SB. Methods : CHAP was applied to 30-Hz triaxial hip-worn ActiGraph-GT3X+ (AG) accelerometer data from free-living postmenopausal women who are overweight (≥55 years) in the Rise for Health RCT ( n = 406). CHAP-predicted SB accuracy (e.g., sensitivity) and daily pattern metrics (e.g., total sedentary time) were compared with a ground-truth device activPAL (AP) and standard cut-point method (AG100) at two timepoints for intervention arms—Healthy Living (control), Reduce Sitting, and Increase Transitions. Results : CHAP’s SB accuracy metrics were above 84.8%. Mean (standard error, p values) intervention effect estimates (mean change, intervention minus controls) from generalized estimating equation models for (a) total sedentary time were AP 65.1 min/day (16.2, p < .001), CHAP 38.2 min/day (15.4, p = .013), and AG100 0.28 min/day (13.9, p = .98; Reduce Sitting); (b) breaks from SB were AP 22/day (4.3, p < .001), CHAP 4/day (1.5, p = .003), and AG100 <1/day (2.1, p = .860; Increase Transitions). Conclusions : This study validated CHAP on an independent cohort. CHAP exhibited high prediction accuracy, and although less sensitive than AP, CHAP detected changes in SB more effectively than AG100. Thus, CHAP could make a strong contribution to SB intervention research.